InPath shows promise for cervical cancer screening
This article was originally published in Clinica
Executive Summary
Ampersand says that a pilot study of its InPath slide-based test system for cervical cancer screening revealed that the product detected all levels of cervical abnormalities with an accuracy of 95%.